O’Melveny represented TYK Medicines in the transaction. TYK Medicines, Inc. (2410.HK) executed its initial public offering and listing on the Main Board of the Hong Kong...
TYK Medicines’ US$74 Million Hong Kong IPO
Shanghai Voicecomm Information Technology’s US$85 Million Initial Public Offering
Ashurst acted as the U.S. counsel to Shanghai Voicecomm Information Technology, while O’Melveny represented the underwriters on the offering. Shanghai Voicecomm Information Technology Co., Ltd. (2495.HK)...
Ruichang International’s HK$131 Million Hong Kong IPO
O’Melveny represented Ruichang International Holdings Limited on the transaction. Ruichang International Holdings Limited (1334.HK) announced its initial public offering and listing on the Main Board of...
Chenghe Acquisition II’s US$86 Million Initial Public Offering
O’Melveny represented Chenghe Acquisition II Co. in the transaction. Chenghe Acquisition II Co. (NYSE: CHEB.U) announced its initial public offering on the New York Stock Exchange....
Laopu Gold’s HK$906 Million HKEX IPO
On the deal, O’Melveny acted for Laopu Gold, Linklaters advised the underwriters. Laopu Gold Co., Ltd. completed the global offering and listing of H shares on...
Qyuns Therapeutics’ US$31 Million Initial Public Offering
O’Melveny represented China International Capital Corporation Hong Kong Securities Limited as the sole sponsor and overall coordinator in the IPO. Qyuns Therapeutics Co., Ltd. (2509.HK) announced...
Folangsi’s HK$155 Million Hong Kong IPO
O’Melveny represented FOLANGSI CO., LTD in the transaction. FOLANGSI CO., LTD (2499.HK) (“FOLANGSI”) announced its approximately HK$155 million initial public offering and listing of H shares...
Beijing UBOX Online Technology Corp.’s HK$233.7 Million Initial Public Offering
O’Melveny assisted Beijing UBOX Online Technology Corp. on the Hong Kong laws. Sidley acted as international legal counsel for the joint sponsors. Beijing UBOX Online Technology...
Beijing Fourth Paradigm Technology’s $150 Million Initial Public Offering
O’Melveny represented the sole sponsor, the coordinators and the underwriters in the transaction. Beijing Fourth Paradigm Technology Co., Ltd. (6682.HK) announced its initial public offering and listing...
Adlai Nortye’s US$100 Million Initial Public Offering
O’Melveny represented Adlai Nortye Ltd. in the transaction. Adlai Nortye Ltd. (NASDAQ: ANL) announced its IPO on the Nasdaq. Adlai Nortye expects to receive aggregate gross...
Acotec Scientific Holdings’ Partial Offering
O’Melveny advised Acotec Scientific Holdings on the deal. Acotec Scientific Holdings, executed a voluntary partial offering for a majority stake of up to 65% by US-listed Boston...
Beauty Farm’s Hong Kong IPO and Listing
O’Melveny advised Beauty Farm. Clifford Chance has advised the joint sponsors. Shearman & Sterling advised Beijing Xinyu Meiye Holdings Limited as a selling shareholder. Beauty Farm...